Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: A quasi-experimental study

Nephrology Dialysis Transplantation

Volumn 29, Issue 8, 2014, Pages 1597-1607

  Joost, Robert ^a   Dörje, Frank ^a   Schwitulla, Judith ^b   Eckardt, Kai Uwe ^b   Hugo, Christian ^c  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

electronic monitoring; kidney transplantation; medication adherence; patient education; pharmaceutical care

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIFIED PHARMACEUTICAL CARE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY;

ELECTRONIC MONITORING; KIDNEY TRANSPLANTATION; MEDICATION ADHERENCE; PATIENT EDUCATION; PHARMACEUTICAL CARE;

ALLOGRAFTS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHARMACEUTICAL SERVICES; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84905006033     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu207     Document Type: Article

References (50)

1. De Bleser L, Dobbels F, Berben L et al. The spectrum of nonadherence with medication in heart, liver, and lung transplant patients assessed in various ways. Transpl Int 2011; 24: 882-891
2. Denhaerynck K, Burkhalter F, Schafer-Keller P et al. Clinical consequences of non-Adherence to immunosuppressive medication in kidney transplant patients. Transpl Int 2009; 22: 441-446
3. Prendergast MB, Gaston RS. Optimizing medication adherence: An ongoing opportunity to improve outcomes after kidney transplantation. Clin J Am Soc Nephrol 2010; 5: 1305-1311
4. Vlaminck H, Maes B, Evers G et al. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004; 4: 1509-1513
5. Denhaerynck K, Dobbels F, Cleemput I et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: A literature review. Transpl Int 2005; 18: 1121-1133
6. Butler JA, Roderick P, Mullee M et al. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review. Transplantation 2004; 77: 769-776
7. Dew MA, DiMartini AF, De Vito Dabbs A et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 2007; 83: 858-873
8. Sellares J, de Freitas DG, Mengel M et al. Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012; 12: 388-399
9. De Geest S, Dobbels F, Fluri C et al. Adherence to the therapeutic regimen in heart, lung, and heart-lung transplant recipients. J Cardiovasc Nurs 2005; 20(Suppl 5): S88-S98
10. Vrijens B, De Geest S, Hughes DA et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012; 73: 691-705
11. Dobbels F, de Geest B. How to identify nonadherence to immunosuppressive medication in organ transplant recipients? In: Oppenheimer F (ed). Current Insights and Future Challanges. Compliance in Solid Organ Transplantation. Barcelona: Permanyer Publications, 2011, pp. 1-19
12. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487-497
13. De Bleser L, Matteson M, Dobbels F et al. Interventions to improve medication-Adherence after transplantation: A systematic review. Transpl Int 2009; 22: 780-797
14. Hilbrands LB, Hoitsma AJ, Koene RA. Medication compliance after renal transplantation. Transplantation 1995; 60: 914-920
15. Nevins TE, Kruse L, Skeans MA et al. The natural history of azathioprine compliance after renal transplantation. Kidney Int 2001; 60: 1565-1570
16. Greenstein S, Siegal B. Compliance and noncompliance in patients with a functioning renal transplant: A multicenter study. Transplantation 1998; 66: 1718-1726
17. Rianthavorn P, Ettenger RB. Medication non-Adherence in the adolescent renal transplant recipient: A clinician's viewpoint. Pediatr Transplant 2005; 9: 398-407
18. Russell CL. A clinical nurse specialist-led intervention to enhance medication adherence using the plan-do-check-Act cycle for continuous self-improvement. Clin Nurse Spec 2010; 24: 69-75
19. Denhaerynck K, Schafer-Keller P, Young J et al. Examining assumptions regarding valid electronic monitoring of medication therapy: Development of a validation framework and its application on a European sample of kidney transplant patients. BMC Med Res Methodol 2008; 8: 5
20. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67-74
21. Chisholm MA, Lance CE, Williamson GM et al. Development and validation of an immunosuppressant therapy adherence barrier instrument. Nephrol Dial Transplant 2005; 20: 181-188
22. Klein A, Otto G, Kramer I. Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: A prospective, randomized, controlled trial using electronic monitoring. Transplantation 2009; 87: 839-847
23. Demonceau J, Ruppar T, Kristanto P et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: A systematic literature review and meta-Analysis. Drugs 2013; 73: 545-562
24. Krolop L, Ko YD, Schwindt PF et al. Adherence management for patients with cancer taking capecitabine: A prospective two-Arm cohort study. BMJ Open 2013; 3: E003139
25. Michie S, Richardson M, Johnston Met al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: Building an international consensus for the reporting of behavior change interventions. Ann Behav Med 2013; 46: 81-95
26. Kuypers DR, Peeters PC, Sennesael JJ et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: A randomized controlled trial using electronic monitoring. Transplantation 2013; 95: 333-340
27. Butt Z, Yount SE, Caicedo JC et al. Quality of life assessment in renal transplant: Review and future directions. Clin Transplant 2008; 22: 292-303
28. McHorney CA,Ware JE, Jr, RogersWet al. The validity and relative precision of MOS short-And long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care 1992; 30(Suppl 5): MS253-MS265
29. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483
30. Bjelland I, Dahl AA, Haug TT et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77
31. Hermann-Lingen C, Buss U, Snaith PR. HADS-D Hospital Anxiety and Depression Scale, Deutsche Version: Manual. Bern: Verlag Hans Huber, 2011
32. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370
33. Jay CL, Butt Z, Ladner DP et al. A review of quality of life instruments used in liver transplantation. J Hepatol 2009; 51: 949-959
34. Karaminia R, Tavallaii SA, Lorgard-Dezfuli-Nejad M et al. Anxiety and depression: A comparison between renal transplant recipients and hemodialysis patients. Transplant Proc 2007; 39: 1082-1084
35. Noohi S, Khaghani-Zadeh M, Javadipour M et al. Anxiety and depression are correlated with higher morbidity after kidney transplantation. Transplant Proc 2007; 39: 1074-1078
36. De Geest S, Schafer-Keller P, Denhaerynck K et al. Supporting medication adherence in renal transplantation (SMART): A pilot RCT to improve adherence to immunosuppressive regimens. Clin Transplant 2006; 20: 359-368
37. Arnsten JH, Demas PA, Farzadegan H et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clin Infect Dis 2001; 33: 1417-1423
38. Bachmann LH, Stephens J, Richey CMet al. Measured versus self-reported compliance with doxycycline therapy for chlamydia-Associated syndromes: High therapeutic success rates despite poor compliance. Sex Transm Dis 1999; 26: 272-278
39. Balakrishnan S, Kumar A, Rao BR et al. Implementation of tests for monitoring drug compliance of leprosy out-patients under multi-drug therapy. Indian J Lepr 1986; 58: 555-559
40. Butler JA, Peveler RC, Roderick P et al. Measuring compliance with drug regimens after renal transplantation: Comparison of self-report and clinician rating with electronic monitoring. Transplantation 2004; 77: 786-789
41. Mason BJ, Matsuyama JR, Jue SG. Assessment of sulfonylurea adherence and metabolic control. Diabetes Educ 1995; 21: 52-57
42. Choo PW, Rand CS, Inui TS et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999; 37: 846-857
43. Lee JY, Kusek JW, Greene PG et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens 1996; 9: 719-725
44. Blaschke T, Osterberg L, Vrijens B et al. Adherence to medications: Insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol 2012; 52: 275-301
45. Ekberg H, Bernasconi C, Tedesco-Silva H et al. Calcineurin inhibitor minimization in the symphony study: Observational results 3 years after transplantation. Am J Transplant 2009; 9: 1876-1885
46. Gaston RS, Cecka JM, Kasiske BL et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 2010; 90: 68-74
47. Ponticelli C, Scolari MP. Calcineurin inhibitors in renal transplantation still needed but in reduced doses: A review. Transplant Proc 2010; 42: 2205-2208
48. Kahan BD, Welsh M, Urbauer DL et al. Low intraindividual variability of cyclosporin A exposure reduces chronic rejection incidence and health care costs. J Am Soc Nephrol 2000; 11: 1122-1131
49. Nevins TE, Thomas W. Quantitative patterns of azathioprine adherence after renal transplantation. Transplantation 2009; 87: 711-718
50. Takemoto SK, Pinsky BW, Schnitzler MA et al. A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients. Am J Transplant 2007; 7: 2704-2711